On the recordJune 22, 2018
Mr. Speaker, I rise today to recognize the work of NephCure Kidney International. Roughly 31 million Americans live with kidney disease, and 3 in every 100,000 people suffer from nephrotic syndrome. Nephrotic syndrome is not a disease itself; rather, it is an umbrella term for the signs and symptoms that result from damage in the kidneys' filtering units. NephCure Kidney International is the only organization committed exclusively to supporting research into finding the cause of the kidney disease focal segmental glomerulosclerosis, or FSGS, and nephrotic syndrome. I am proud of the work of this organization and their leaader, Dr. Irving Smokler, NephCure's president and founder and a constituent of mine. In 1999, Dr. Smokler launched the NephCure Foundation, inspired by his son, Matthew, who was diagnosed with FSGS when he was just 11 years old. Dr. Smokler has since dedicated himself to the fulfillment of the foundation's mission: to find the cause of and cure for FSGS and nephrotic syndrome. Mr. Speaker, today I call on all of our colleagues to recognize and support the goals of this important organization and to support robust funding for research at NIH to help find a cure for FSGS and nephrotic syndrome. ____________________





